Research Article
[Retracted] Prognostic Value of Lactate Dehydrogenase, Melanoma Inhibitory Protein, and S-100B Protein in Patients with Malignant Melanoma
Table 3
Comparative analysis of serum LDH, MIA, and S-100B levels in differing clinical stages (x ± s).
| | AJCC stage | LDH (mg/l) | MIA (ng/ml) | S-100B (ug/l) |
| | Stage I (n = 9) | 15.63 ± 1.89 | 2.99 ± 1.48 | 0.47 ± 0.17 | | Stage II (n = 38) | 30.19 ± 4.31a | 6.39 ± 2.75a | 0.97 ± 0.37a | | Stage III (n = 24) | 51.53 ± 5.43ab | 11.58 ± 2.70ab | 1.34 ± 0.42ab | | Stage IV (n = 13) | 71.52 ± 10.28abc | 15.84 ± 2.83abc | 2.06 ± 0.47abc | | F-value | 250.393 | 64.176 | 37.142 | | -value | <0.001 | <0.001 | <0.001 |
|
|
Note: Compared with stage I, a; compared with stage, b; Compared with stage III, c. |